parkinson's disease triple agonist glp-1 gip glucagon clinical trial Diabetes, obesity, and possible actions of Role of glucagon-like peptide-1 receptor

A reminder that their story doesnt start in Hollywood

Learn how GLP-1 drugs can help you lose weight, which ones are best, and where to get them.

The World Obesity Atlas 2024 reports over 1.5 billion projected cases by 2035, highlighting its growing threat among pediatric and adult populations globally

Understand causes, benefits, and practical insights to support better health and informed decisions.

Glucagon-like peptide-1 (GLP-1) is an incretin peptide hormone mainly secreted by enteroendocrine intestinal L-cells

Purpose Chronic kidney disease (CKD) is one of the most common complications of type 2 diabetes (T2D), and CKD-related disability and mortality are increasing despite the recent advances in diabetes management